(March 20, 2014) A group of French researchers conducted a randomized, phase III trial (called AURELIA) combining bevacizumab (Avastin) with chemotherapy in platinum-resistant ovarian cancer. The results of the trial, … Continued
This week, a new analysis showed that women that are overweight or obese have a moderately higher risk of developing ovarian cancer than women at normal weight. The study, released … Continued
(March 14, 2014) A large European clinical trial showed that carboplatin plus paclitaxel once a week (versus every three weeks) can be an effective front-line treatment for women with advanced … Continued
OCRF-funded research at UC Davis have verified that glycans (sugars attached to proteins) can be used to identify ovarian cancer. The study was published online in the journal Cancer Epidemiology, Biomarkers … Continued
New research published this week suggests that women with BRCA1 mutations should have a prophylactic oophorectomy by the age of 35 to lessen their risk of developing and dying from … Continued
The findings of a large international study published in the Journal of Clinical Oncology suggest for the first time that women with BRCA1 mutations should have preventive ovarian surgery (prophylactic … Continued
(February 21, 2014) Scientists at the University of Kansas Medical Center have determined that high doses of vitamin C, administered intravenously with traditional chemotherapy, helped kill cancer cells while reducing … Continued
High-doses of vitamin C delivered in conjunction with IV chemotherapy may boost chemotherapy’s effectiveness and reduce side-effects in ovarian cancer treatment, according to a new study published this week. Researchers … Continued
(February 10, 2014) Women who take aspirin daily may reduce their risk of ovarian cancer by 20 percent, according to a study by scientists at the National Cancer Institute (NCI). … Continued
FOR IMMEDIATE RELEASE: February 7, 2014 Further Study Needed Before Clinical Recommendations Change Washington, DC—A study published yesterday by the National Institutes of Health found that women who took aspirin … Continued
(January 31, 2014) A new study conservatively estimates that one in five women with ovarian cancer has inherited genetic mutations that increase the risk of the disease, according to research … Continued
(January 30, 2014) OCRF grantee Yin Wang, PhD, led research which found that PKC iota signaling plays an important role in ovarian cancer development. The research, which was published in … Continued
Get email updates about research news, action alerts, and ways to join the fight.
